|
Malyarenko, Dariya I; Cooke, William E; Adam, Bao-Ling et al. (2005) Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. Clin Chem 51:65-74
|
|
Clark, N M; Hannibal, M C; Markovitz, D M (1995) The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells. J Virol 69:4854-62
|
|
Markovitz, D M (1993) Infection with the human immunodeficiency virus type 2. Ann Intern Med 118:211-8
|
|
Hilfinger, J M; Clark, N; Smith, M et al. (1993) Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation. J Virol 67:4448-53
|
|
Clark, N M; Smith, M J; Hilfinger, J M et al. (1993) Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J Virol 67:5522-8
|
|
Markovitz, D M; Hannibal, M C; Smith, M J et al. (1992) Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1. J Virol 66:3961-5
|
|
Markovitz, D M; Smith, M J; Hilfinger, J et al. (1992) Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements. J Virol 66:5479-84
|
